Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA …
Pharma News | BioPharma Dive
Nov 14, 2024 · Halozyme bids for Evotec; BeiGene gets a new name. The San Diego biotech made an unsolicited bid to buy Evotec for 2 billion euros. Elsewhere, Bluebird recorded its first …
Meso Scale Discovery (MSD): An immunoassay platform with …
Feb 22, 2022 · ADVANTAGES. Sensitivity, Range and Ease-of-Use: In comparison to a conventional ELISA, MSD has higher sensitivity (LLOD 0.1-1.4 pg/mL) and a larger dynamic …
Biotech News - BioPharma Dive
4 days ago · Surviving in biotech’s new normal: 5 tips from industry VCs and CEOs. At an event hosted by BioPharma Dive, drugmaker executives and investors discussed the importance of …
Investors put $400M into biotech licensing obesity drugs from China
May 16, 2024 · Four life science investors are pouring $400 million into a new biotechnology startup that’s licensed a portfolio of weight loss medicines from Chinese drugmaker Jiangsu …
Clinical Trial News - BioPharma Dive
6 days ago · Roche weighs whether speedy approval path is open for latest Alzheimer’s drug. In an investor presentation, executives hinted at the possibility of seeking an accelerated …
Novartis wins FDA approval for new heart drug, but faces uphill …
Dec 22, 2021 · Novartis priced Leqvio at $3,250 per dose for U.S. sale, meaning the first year of treatment will cost $9,750 and subsequent years $6,500. That’s slightly higher than the $5,400 …
Zepbound, Mounjaro back in supply as Lilly resolves shortage
Aug 5, 2024 · The company in April raised its financial forecasts for the year by $2 billion due to revenue growth for Zepbound and Mounjaro, which together brought in $2.3 billion between …
BioMarin finally secures FDA approval of hemophilia gene therapy
Jun 29, 2023 · The Food and Drug Administration approved on Thursday the first gene therapy for the most common form of hemophilia, clearing the way for what patients, doctors and the …
Lilly reports strong results for next-generation diabetes drug
Dec 9, 2020 · Dive Brief: Eli Lilly on Wednesday said its experimental diabetes drug tirzepatide succeeded in its first Phase 3 trial, reporting results showing treatment significantly lowered …